Farid Boulad

11.0k total citations · 2 hit papers
167 papers, 5.7k citations indexed

About

Farid Boulad is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Farid Boulad has authored 167 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hematology, 56 papers in Oncology and 36 papers in Immunology. Recurrent topics in Farid Boulad's work include Hematopoietic Stem Cell Transplantation (67 papers), Acute Lymphoblastic Leukemia research (30 papers) and Acute Myeloid Leukemia Research (29 papers). Farid Boulad is often cited by papers focused on Hematopoietic Stem Cell Transplantation (67 papers), Acute Lymphoblastic Leukemia research (30 papers) and Acute Myeloid Leukemia Research (29 papers). Farid Boulad collaborates with scholars based in United States, Italy and Netherlands. Farid Boulad's co-authors include Nancy A. Kernan, Hugo Castro‐Malaspina, Stephen Mackinnon, Richard J. O’Reilly, Alfred P. Gillio, Esperanza B. Papadopoulos, James W. Young, Trudy N. Small, Glenn Heller and Charles A. Sklar and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Farid Boulad

163 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation

1994 809 citations Esperanza B. Papadopoulos, Farid Boulad et al. profile →
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1995 600 citations Farid Boulad, Hugo Castro‐Malaspina et al. Blood profile →

Peers

Countries citing papers authored by Farid Boulad

Since Specialization

Citations

This map shows the geographic impact of Farid Boulad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farid Boulad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farid Boulad more than expected).

Fields of papers citing papers by Farid Boulad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farid Boulad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farid Boulad. The network helps show where Farid Boulad may publish in the future.

Co-authorship network of co-authors of Farid Boulad

This figure shows the co-authorship network connecting the top 25 collaborators of Farid Boulad. A scholar is included among the top collaborators of Farid Boulad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farid Boulad. Farid Boulad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients 2024 ·Cytotherapy ·(unknown), Audrey Mauguen, Farid Boulad, Maria Cancio, (unknown), Andrew C. Harris, Nancy A. Kernan, Elizabeth Klein, Andrew L. Kung, Joseph H. Oved, Susan E. Prockop, Andromachi Scaradavou, Barbara Spitzer, Richard J. O’Reilly, Jaap Jan Boelens	4
2	T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML 2023 ·Bone Marrow Transplantation ·(unknown), Elizabeth Klein, Audrey Mauguen, (unknown), Jaap Jan Boelens, Maria Cancio, Kevin J. Curran, Nancy A. Kernan, Susan E. Prockop, Andromachi Scaradavou, Barbara Spitzer, Roni Tamari, (unknown), (unknown), Parinda A. Mehta, Richard J. O’Reilly, Farid Boulad	1
3	Pneumatosis intestinalis in the pediatric oncology population: An 11‐year retrospective review at Memorial Sloan Kettering Cancer Center 2021 ·Pediatric Blood & Cancer ·Kayleen Bailey, (unknown), Audrey Mauguen, Anita P. Price, Michael P. LaQuaglia, Farid Boulad	3
4	Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia 2021 ·Transplantation and Cellular Therapy ·Maria Cancio, Kyle Hebert, Soyoung Kim, Mahmoud Aljurf, Timothy S. Olson, Eric Anderson, Lauri M. Burroughs, (unknown), Kasiani C. Myers, Hasan Hashem, Rabi Hanna, Biljana Horn, Tim Prestidge, Jaap Jan Boelens, Farid Boulad, Mary Eapen	12
5	Rapid Virologic Response to Brincidofovir in Children with Disseminated Adenovirus Infection 2021 ·Infection and Chemotherapy ·(unknown), Susan E. Prockop, Farid Boulad, Genovefa A. Papanicolaou, Yeon Joo Lee	2
6	Gene Therapy and Genome Editing 2018 ·Hematology/Oncology Clinics of North America ·Farid Boulad, Jorge Mansilla‐Soto, Annalisa Cabriolu, Isabelle Rivière, Michel Sadelain	20
7	The Clinical and Hematologic Course of Fanconi Anemia Amongst Affected Siblings 2017 ·Blood ·Moonjung Jung, (unknown), Caroline S. Jiang, Joel Corrêa da Rosa, (unknown), Agata Smogorzewska, Farid Boulad	1
8	Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma 2017 ·Blood ·Nitya Gulati, Farid Boulad, Maria Cancio, Kevin J. Curran, Carolyn C. Jackson, Nancy A. Kernan, Andrew L. Kung, Richard J. O’Reilly, Susan E. Prockop, Kavitha Ramaswamy, Andromachi Scaradavou, Barbara Spitzer, Neerav Shukla, Peter G. Steinherz, Christopher J. Forlenza	1
9	Safety and Efficacy Trial of Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells (HPCs) for Globin Gene Transfer in Patients with Sickle Cell Disease 2017 ·Blood ·Farid Boulad, Tsiporah B. Shore, Koen van Besien, (unknown), (unknown), Caterina P. Minniti, (unknown), Fabiana Perna, Xiuyan Wang, Isabelle Rivière, Michel Sadelain, Patricia A. Shi	3
10	High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL 2017 ·Blood ·Kevin J. Curran, Steven Margossian, Nancy A. Kernan, Lewis B. Silverman, Jae H. Park, Craig S. Sauter, Eric L. Smith, Farid Boulad, Maria Cancio, Christopher J. Forlenza, Carolyn C. Jackson, Neerav Shukla, Barbara Spitzer, Susan E. Prockop, Peter G. Steinherz, Andrew L. Kung, Richard J. O’Reilly, Isabelle Rivière, Michel Sadelain, Renier J. Brentjens	1
11	A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies 2017 ·Biology of Blood and Marrow Transplantation ·Barbara Spitzer, Ann A. Jakubowski, Esperanza B. Papadopoulos, (unknown), Patrick Hilden, James W. Young, Juliet N. Barker, Guenther Koehne, Miguel‐Angel Perales, Katharine C. Hsu, Marcel R.M. van den Brink, Nancy A. Kernan, Susan E. Prockop, Andromachi Scaradavou, Hugo Castro‐Malaspina, Richard J. O’Reilly, Farid Boulad	8
12	Control of norovirus outbreak on a pediatric oncology unit 2015 ·American Journal of Infection Control ·(unknown), (unknown), Lauren Richardson, (unknown), Alexander J. Chou, N. Esther Babady, Yi‐Wei Tang, Farid Boulad, Janet Eagan, Kent A. Sepkowitz, Mini Kamboj	14
13	Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature 2011 ·Haematologica ·David J. Araten, Rosario Notaro, Howard T. Thaler, Nancy A. Kernan, Farid Boulad, Hugo Castro‐Malaspina, Trudy N. Small, Andromachi Scaradavou, Heather Magnan, Susan E. Prockop, Sara Chaffee, (unknown), Raymond Thertulien, Roberto Tarquini, Lucio Luzzatto	20
14	Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT 2010 ·Bone Marrow Transplantation ·(unknown), Robert R. Jenq, Jeffrey L. Goldberg, Andrew S. Wilton, (unknown), Hugo Castro‐Malaspina, Katharine C. Hsu, Evangelos Papadopoulos, Marcel R.M. van den Brink, Farid Boulad, Nancy A. Kernan, Trudy N. Small, Suzanne L. Wolden, N H Collins, Michelle Chiu, Glenn Heller, R.J. O’Reilly, Tarun Kewalramani, James W. Young, Ann A. Jakubowski	17
15	Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system 2009 ·Pediatric Blood & Cancer ·Stephen W. Gilheeney, Yasmin Khakoo, (unknown), Suzanne L. Wolden, Farid Boulad, Ira J. Dunkel	18
16	Postexposure Prophylaxis Against Varicella-Zoster Virus Infection Among Recipients of Hematopoietic Stem Cell Transplant: Unresolved Issues 2004 ·Infection Control and Hospital Epidemiology ·David M. Weinstock, Michael Boeckh, Farid Boulad, Janet Eagan, Victoria J. Fraser, David K. Henderson, Trish M. Perl, Deborah S. Yokoe, Kent A. Sepkowitz	24
17	LUNG TRANSPLANTATION AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PEDIATRIC PATIENTS 2001 ·Transplantation ·John A. Heath, Geoffrey Kurland, Thomas L. Spray, Nancy A. Kernan, (unknown), Joel A. Brochstein, Alfred P. Gillio, Jessica Boklan, (unknown), Farid Boulad	27
18	Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria 2001 ·British Journal of Haematology ·David J. Araten, David Swirsky, Anastasios Karadimitris, Rosario Notaro, Khédoudja Nafa, Monica Bessler, Howard T. Thaler, Hugo Castro‐Malaspina, Barrett H. Childs, Farid Boulad, Mark A. Weiss, Nikolaos Anagnostopoulos, Abdullah Kutlar, David G. Savage, Richard T. Maziarz, Suresh C. Jhanwar, Lucio Luzzatto	34
19	Posterior leukoencephalopathy syndrome may not be reversible 1999 ·Pediatric Neurology ·Nuno Lobo Antunes, Trudy N. Small, Diane George, Farid Boulad, (unknown)	128
20	Treatment of Childhood Acute Nonlymphoblastic Leukemia: A Review 1993 ·Cancer Investigation ·Farid Boulad, Nancy A. Kernan	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact